Pressure BioSciences (OTCQB: PBIO), a leader in the
development and sale of high pressure-based instruments, consumables, and
related services for the global life sciences industry, today released a short
video that demonstrates its proprietary Ultra Shear Technology (“UST”) platform
and its ability to create nanoemulsions (extremely small, nanometer-scale oil
droplets that effectively dissolve in water) to provide optimized
bioavailability for absorption. “We have all observed how oil and water do not
normally mix or dissolve in each other, and routinely separate after mixing,”
Pressure BioSciences Chief Commercial Officer Dr. Bradford A. Young said in the
news release. “Even with modern, advanced mixing technologies, oils remain in
relatively large drops in water, which are poorly absorbed by the body. PBI’s
proprietary UST platform employs ultra-high pressure and extreme shearing
forces to create very small, nano-scale emulsions (nanoemulsions) of oil
droplets in water with vastly improved absorption and stability
characteristics.”
To view the full press release, visit http://ibn.fm/w1H6s
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. is a leader in the development
and sale of innovative, broadly enabling, pressure-based solutions for the
worldwide life sciences industry. The company’s products are based on the
unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil & plant biology, forensics, and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of its pressure-based technologies in the following areas:
(1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to
allow entry into the biologics contract research services sector, and (2) the
use of its recently-patented, scalable, high-efficiency, pressure-based Ultra
Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher
quality, homogenized, extended shelf-life or room temperature stable low-acid
liquid foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
